Literature DB >> 10740149

Peripheral resistance vessel dysfunction in Marfan syndrome.

M Nakamura1, S Itoh, S Makita, A Ohira, N Arakawa, K Hiramori.   

Abstract

BACKGROUND: Patients with Marfan syndrome show a hereditary abnormality of elastin metabolism that may cause aortic enlargement and dissection. We have hypothesized that abnormal elastin may alter peripheral vascular structure and function.
METHODS: Forearm blood flow (FBF) (in milliliters per minute per 100 mL) response to the endothelium-dependent dilator acetylcholine (0.75 to 4.5 microg/min per 100 mL), the endothelium-independent dilator sodium nitroprusside (0.05 to 0.3 microg/min per 100 mL), and structure-related maximum dilator response (10-minute occlusion-induced reactive hyperemia) were measured by plethysmograph in 10 patients with Marfan syndrome (mean age 44 years) and 10 healthy age- and sex-matched controls. Patients with the complications of hypercholesterolemia, diabetes mellitus, or heart failure were excluded from the study.
RESULTS: Basal FBF (mean +/- SE) did not differ between the 2 groups (2.7 +/- 0.3 vs 2.3 +/- 0.4). Maximum FBF response to acetylcholine in patients with Marfan syndrome was significantly lower than that of healthy controls (8.5 +/- 2.1 vs 15.4 +/- 1.7 mL/min per 100 mL; P <.05). Reactive hyperemia was also lower in patients with Marfan syndrome (at peak 23.0 +/- 2.5 vs 29.5 +/- 2.3 mL/min per 100 mL; P <.05), but sodium nitroprusside-induced FBF changes did not differ between the 2 groups (10.3 +/- 1.1 vs 10.2 +/- 1.5 mL/min per 100 mL; P = not significant).
CONCLUSION: These observations suggest that endothelium-dependent dilation and maximum dilator reserve capacity are both abnormal in peripheral resistance vessels of patients with Marfan syndrome. These peripheral vasomotion abnormalities may have a detrimental impact on the cardiovascular system in this disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740149     DOI: 10.1016/s0002-8703(00)90045-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  [Acute carpal tunnel syndrome in a patient with Marfan syndrome].

Authors:  J Franke; W Wenzel; D Rehfuss; H P Keiner; K Manncke
Journal:  Unfallchirurg       Date:  2008-05       Impact factor: 1.000

2.  Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome.

Authors:  Munenori Takata; Eisuke Amiya; Masafumi Watanabe; Kazuko Omori; Yasushi Imai; Daishi Fujita; Hiroshi Nishimura; Masayoshi Kato; Tetsuro Morota; Kan Nawata; Atsuko Ozeki; Aya Watanabe; Shuichi Kawarasaki; Yumiko Hosoya; Tomoko Nakao; Koji Maemura; Ryozo Nagai; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2013-07-14       Impact factor: 2.037

3.  Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.

Authors:  A W Y Chung; K Au Yeung; S F Cortes; G G S Sandor; D P Judge; H C Dietz; C van Breemen
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

4.  Comprehensive Characterization of Arterial and Cardiac Function in Marfan Syndrome-Can Biomarkers Help Improve Outcome?

Authors:  Constance G Weismann; Joanna Hlebowicz; Anna Åkesson; Petru Liuba; Katarina Hanseus
Journal:  Front Physiol       Date:  2022-04-25       Impact factor: 4.755

5.  Losartan Attenuates Degradation of Aorta and Lung Tissue Micromechanics in a Mouse Model of Severe Marfan Syndrome.

Authors:  Jia-Jye Lee; Josephine Galatioto; Satish Rao; Francesco Ramirez; Kevin D Costa
Journal:  Ann Biomed Eng       Date:  2016-04-18       Impact factor: 3.934

6.  Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome.

Authors:  H T Syyong; A W Y Chung; H H C Yang; C van Breemen
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

7.  Augmentation index assessed by applanation tonometry is elevated in Marfan Syndrome.

Authors:  Rupert A Payne; Roland C Hilling-Smith; David J Webb; Simon R Maxwell; Martin A Denvir
Journal:  J Cardiothorac Surg       Date:  2007-10-23       Impact factor: 1.637

Review 8.  Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome.

Authors:  Keiichi Asano; Anna Cantalupo; Lauriane Sedes; Francesco Ramirez
Journal:  Biomolecules       Date:  2022-01-14

9.  Association of NFE2L2 Gene Polymorphisms with Risk and Clinical Characteristics of Acute Type A Aortic Dissection in Han Chinese Population.

Authors:  Yiran Zhang; Qi Zheng; Ruoshi Chen; Xiaoyi Dai; Yimin Zhu; Liang Ma
Journal:  Oxid Med Cell Longev       Date:  2021-07-17       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.